A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Systolic blood pressure <90 mm Hg for 30 minutes before inotropes/vasopressors, or vasopressors or IABP are required to maintain systolic blood pressure ≥90 mm Hg ...

Sex‐related differences in Takotsubo syndrome have been described, but no information is available in patients who develop cardiogenic shock. Sex does not affect the prognosis once cardiogenic shock ...

An 8-year-old girl from Ho Chi Minh City has defied the odds, surviving a critical case of antibiotic-resistant septic shock ...

CS may present as an early complication following ST elevation and MI. In the SHOCK trial, the median time from MI to shock onset was 5.0 hours (25th to 75th percentile, 2.2-12.0 hours ...

Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech, the global leader in heart recovery, announced ...

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

Impella 5.5 and Impella CP are the first left-sided, minimally invasive temporary mechanical circulatory support options for pediatric patients with symptomatic ADHF and cardiogenic shock Impella ...

WARRINGTON, PA — Windtree Therapeutics, Inc. has announced a new patent application for istaroxime derivatives, aimed at preventing or reducing the risk of acute myocardial arrhythmia. The filing ...

12, 2024 /PRNewswire/ -- Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech ... and conventional ...